Anti-IL23R monoclonal antibody
Anti-IL23R antibody for FACS & in-vivo assay
Go to IL23R/IL23R products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-T00484-Ab-1/ GM-Tg-hg-T00484-Ab-2 | Anti-Human IL23R monoclonal antibody | Human |
GM-Tg-rg-T00484-Ab-1/ GM-Tg-rg-T00484-Ab-2 | Anti-Rat IL23R monoclonal antibody | Rat |
GM-Tg-mg-T00484-Ab-1/ GM-Tg-mg-T00484-Ab-2 | Anti-Mouse IL23R monoclonal antibody | Mouse |
GM-Tg-cynog-T00484-Ab-1/ GM-Tg-cynog-T00484-Ab-2 | Anti-Cynomolgus/ Rhesus macaque IL23R monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-T00484-Ab-1/ GM-Tg-felg-T00484-Ab-2 | Anti-Feline IL23R monoclonal antibody | Feline |
GM-Tg-cang-T00484-Ab-1/ GM-Tg-cang-T00484-Ab-2 | Anti-Canine IL23R monoclonal antibody | Canine |
GM-Tg-bovg-T00484-Ab-1/ GM-Tg-bovg-T00484-Ab-2 | Anti-Bovine IL23R monoclonal antibody | Bovine |
GM-Tg-equg-T00484-Ab-1/ GM-Tg-equg-T00484-Ab-2 | Anti-Equine IL23R monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-T00484-Ab-1/ GM-Tg-hg-T00484-Ab-2; GM-Tg-rg-T00484-Ab-1/ GM-Tg-rg-T00484-Ab-2; GM-Tg-mg-T00484-Ab-1/ GM-Tg-mg-T00484-Ab-2; GM-Tg-cynog-T00484-Ab-1/ GM-Tg-cynog-T00484-Ab-2; GM-Tg-felg-T00484-Ab-1/ GM-Tg-felg-T00484-Ab-2; GM-Tg-cang-T00484-Ab-1/ GM-Tg-cang-T00484-Ab-2; GM-Tg-bovg-T00484-Ab-1/ GM-Tg-bovg-T00484-Ab-2; GM-Tg-equg-T00484-Ab-1/ GM-Tg-equg-T00484-Ab-2 |
Products Name | Anti-IL23R monoclonal antibody |
Format | mab |
Target Name | IL23R |
Protein Sub-location | Transmembrane Protein |
Category of antibody | FACS/Biofunctional Antibody, Therapeutics Target antibody, Cytokine antibody |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD). |
Tag | Fc |
Products description | Pre-made anti-IL23R benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | Products Developing | Multi-species IL23R VLP (virus-like particle) (Products Developing) |
Cytokine | GM-Tg-g-T00484-Ag-1 | Interleukin 23 receptor (IL23R) protein |
ORF Viral Vector | vGMLP004146 | human IL23R Lentivirus particle |
ORF Viral Vector | pGMLP004146 | human IL23R Lentivirus plasmid |
Target information
Target ID | GM-T00484 |
Target Name | IL23R |
Gene ID | 149233,209590,689932,700440,609732,101087763,614367,100053807 |
Gene Symbol and Synonyms | IL-23R,IL23R,PSORS7 |
Uniprot Accession | Q5VWK5 |
Uniprot Entry Name | IL23R_HUMAN |
Protein Sub-location | Transmembrane Protein |
Category | Therapeutics Target, Cytokine Target |
Disease | N/A |
Gene Ensembl | ENSG00000162594 |
Target Classification | N/A |
The target: IL23R, gene name: IL23R, also named as . The protein encoded by this gene is a subunit of the receptor for IL23A/IL23. This protein pairs with the receptor molecule IL12RB1/IL12Rbeta1, and both are required for IL23A signaling. This protein associates constitutively with Janus kinase 2 (JAK2), and also binds to transcription activator STAT3 in a ligand-dependent manner. .
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.